Guided Therapeutics, Inc.
GTHP
$0.25
$0.0525.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.57% | -33.87% | -32.23% | -22.27% | -16.93% |
| Total Depreciation and Amortization | 5.00% | 9.28% | 12.63% | 10.75% | 11.11% |
| Total Amortization of Deferred Charges | 1.03% | 55.17% | 121.82% | 116.19% | 69.57% |
| Total Other Non-Cash Items | 44.05% | 970.15% | 775.56% | 695.59% | 788.57% |
| Change in Net Operating Assets | 28.53% | 10.73% | -1.40% | -12.47% | -22.19% |
| Cash from Operations | -15.25% | -0.30% | 4.56% | 1.25% | -16.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -34.91% | 24.53% | -7.50% | 59.69% | 271.00% |
| Total Debt Repaid | -30.78% | -5.54% | -13.21% | -76.36% | -32.81% |
| Issuance of Common Stock | 48.75% | 48.75% | -7.54% | 84.84% | 331.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.37% | -100.00% | -3.45% | -113.79% | -235.29% |
| Cash from Financing | 9.71% | 57.84% | -18.67% | 71.33% | 2,937.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.22% | 176.97% | -60.10% | 80.07% | 91.69% |